CB3: 10-PROPARGYL-5,8-DIDEAZAFOLIC ACID
CB3 is a Ligand Of Interest in 3DL5 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3DL5_CB3_B_608 | 40% | 19% | 0.205 | 0.917 | 1.29 | 2.12 | 2 | 9 | 4 | 0 | 100% | 1 |
| 3DL5_CB3_C_612 | 36% | 18% | 0.209 | 0.902 | 1.3 | 2.19 | 3 | 9 | 3 | 0 | 100% | 1 |
| 3DL5_CB3_A_604 | 19% | 22% | 0.245 | 0.837 | 1.26 | 1.99 | 2 | 8 | 6 | 0 | 100% | 1 |
| 3DL5_CB3_D_616 | 7% | 21% | 0.328 | 0.779 | 1.23 | 2.08 | 2 | 9 | 12 | 1 | 100% | 1 |
| 3DL5_CB3_E_620 | 5% | 21% | 0.314 | 0.729 | 1.26 | 2.02 | 2 | 10 | 20 | 1 | 100% | 1 |
| 2OIP_CB3_B_608 | 65% | 2% | 0.109 | 0.909 | 3.25 | 3.17 | 25 | 20 | 13 | 0 | 100% | 1 |
| 3DL6_CB3_C_612 | 22% | 21% | 0.29 | 0.906 | 1.29 | 2.01 | 3 | 9 | 21 | 0 | 100% | 1 |
| 1QZF_CB3_E_620 | 14% | 12% | 0.28 | 0.835 | 2.05 | 2 | 11 | 5 | 6 | 1 | 100% | 1 |
| 3HJ3_CB3_A_604 | 3% | 12% | 0.375 | 0.705 | 2.11 | 2.01 | 12 | 6 | 13 | 1 | 100% | 1 |
| 4GEV_CB3_A_702 | 96% | 26% | 0.058 | 0.966 | 1.18 | 1.82 | 3 | 8 | 8 | 0 | 100% | 1 |
| 6NNR_CB3_B_302 | 93% | 19% | 0.076 | 0.97 | 1.19 | 2.25 | 3 | 8 | 0 | 0 | 100% | 1 |
| 2AAZ_CB3_E_2551 | 92% | 5% | 0.081 | 0.973 | 2.5 | 2.75 | 16 | 15 | 0 | 0 | 100% | 0.25 |
| 2FTO_CB3_X_266 | 82% | 17% | 0.087 | 0.943 | 1.58 | 2 | 6 | 6 | 5 | 0 | 100% | 1 |
| 4EIL_CB3_G_702 | 76% | 9% | 0.105 | 0.941 | 1.96 | 2.43 | 8 | 13 | 1 | 0 | 100% | 1 |
